Reply to the Letter to the Editor: "It is urgent to evaluate the efficacy and safety of genotype guided antiplatelet therapy in patients after percutaneous coronary intervention in East Asian"

Abdullah M Al-Rubaish; Fahad A Al-Muhanna; Abdullah M Alshehri; Mohammed A Al-Mansori; Rudaynah A Alali; Rania M Khalil; Khalid A Al-Faraidy; Cyril Cyrus; Mohammed M Sulieman; Chittibabu Vatte; Bao-Li Loza; Daniel M F Claassens; Folkert W Asselbergs; Amein K Al-Ali

doi:https://doi.org/10.1016/j.ijcard.2021.11.069

Reply to the Letter to the Editor: "It is urgent to evaluate the efficacy and safety of genotype guided antiplatelet therapy in patients after percutaneous coronary intervention in East Asian"

Abdullah M Al-Rubaish, Fahad A Al-Muhanna, Abdullah M Alshehri, Mohammed A Al-Mansori, Rudaynah A Alali, Rania M Khalil, Khalid A Al-Faraidy, Cyril Cyrus, Mohammed M Sulieman, Chittibabu Vatte, Bao-Li Loza, Daniel M F Claassens, Folkert W Asselbergs, Amein K Al-Ali

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	57
Number of pages	1
Journal	International journal of cardiology
Volume	348
DOIs	https://doi.org/10.1016/j.ijcard.2021.11.069
Publication status	Published - 1 Feb 2022
Externally published	Yes

Keywords

Cytochrome P-450 CYP2C19/genetics
Genotype
Humans
Percutaneous Coronary Intervention/adverse effects
Platelet Aggregation Inhibitors/adverse effects

Access to Document

https://doi.org/10.1016/j.ijcard.2021.11.069

Cite this

Al-Rubaish, A. M., Al-Muhanna, F. A., Alshehri, A. M., Al-Mansori, M. A., Alali, R. A., Khalil, R. M., Al-Faraidy, K. A., Cyrus, C., Sulieman, M. M., Vatte, C., Loza, B.-L., Claassens, D. M. F., Asselbergs, F. W., & Al-Ali, A. K. (2022). Reply to the Letter to the Editor: "It is urgent to evaluate the efficacy and safety of genotype guided antiplatelet therapy in patients after percutaneous coronary intervention in East Asian". International journal of cardiology, 348, 57. https://doi.org/10.1016/j.ijcard.2021.11.069

@article{834af45b65bf45d9a301441b5efb7ed2,

title = "Reply to the Letter to the Editor: {"}It is urgent to evaluate the efficacy and safety of genotype guided antiplatelet therapy in patients after percutaneous coronary intervention in East Asian{"}",

keywords = "Cytochrome P-450 CYP2C19/genetics, Genotype, Humans, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors/adverse effects",

author = "Al-Rubaish, {Abdullah M} and Al-Muhanna, {Fahad A} and Alshehri, {Abdullah M} and Al-Mansori, {Mohammed A} and Alali, {Rudaynah A} and Khalil, {Rania M} and Al-Faraidy, {Khalid A} and Cyril Cyrus and Sulieman, {Mohammed M} and Chittibabu Vatte and Bao-Li Loza and Claassens, {Daniel M F} and Asselbergs, {Folkert W} and Al-Ali, {Amein K}",

year = "2022",

month = feb,

day = "1",

doi = "https://doi.org/10.1016/j.ijcard.2021.11.069",

language = "English",

volume = "348",

pages = "57",

journal = "International journal of cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

}

Al-Rubaish, AM, Al-Muhanna, FA, Alshehri, AM, Al-Mansori, MA, Alali, RA, Khalil, RM, Al-Faraidy, KA, Cyrus, C, Sulieman, MM, Vatte, C, Loza, B-L, Claassens, DMF, Asselbergs, FW & Al-Ali, AK 2022, 'Reply to the Letter to the Editor: "It is urgent to evaluate the efficacy and safety of genotype guided antiplatelet therapy in patients after percutaneous coronary intervention in East Asian"', International journal of cardiology, vol. 348, pp. 57. https://doi.org/10.1016/j.ijcard.2021.11.069

Reply to the Letter to the Editor: "It is urgent to evaluate the efficacy and safety of genotype guided antiplatelet therapy in patients after percutaneous coronary intervention in East Asian". / Al-Rubaish, Abdullah M; Al-Muhanna, Fahad A; Alshehri, Abdullah M et al.
In: International journal of cardiology, Vol. 348, 01.02.2022, p. 57.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Reply to the Letter to the Editor: "It is urgent to evaluate the efficacy and safety of genotype guided antiplatelet therapy in patients after percutaneous coronary intervention in East Asian"

AU - Al-Rubaish, Abdullah M

AU - Al-Muhanna, Fahad A

AU - Alshehri, Abdullah M

AU - Al-Mansori, Mohammed A

AU - Alali, Rudaynah A

AU - Khalil, Rania M

AU - Al-Faraidy, Khalid A

AU - Cyrus, Cyril

AU - Sulieman, Mohammed M

AU - Vatte, Chittibabu

AU - Loza, Bao-Li

AU - Claassens, Daniel M F

AU - Asselbergs, Folkert W

AU - Al-Ali, Amein K

PY - 2022/2/1

Y1 - 2022/2/1

KW - Cytochrome P-450 CYP2C19/genetics

KW - Genotype

KW - Humans

KW - Percutaneous Coronary Intervention/adverse effects

KW - Platelet Aggregation Inhibitors/adverse effects

UR - http://www.scopus.com/inward/record.url?scp=85122665535&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.ijcard.2021.11.069

DO - https://doi.org/10.1016/j.ijcard.2021.11.069

M3 - Article

C2 - 34896105

SN - 0167-5273

VL - 348

SP - 57

JO - International journal of cardiology

JF - International journal of cardiology

ER -

Al-Rubaish AM, Al-Muhanna FA, Alshehri AM, Al-Mansori MA, Alali RA, Khalil RM et al. Reply to the Letter to the Editor: "It is urgent to evaluate the efficacy and safety of genotype guided antiplatelet therapy in patients after percutaneous coronary intervention in East Asian". International journal of cardiology. 2022 Feb 1;348:57. doi: https://doi.org/10.1016/j.ijcard.2021.11.069

Reply to the Letter to the Editor: "It is urgent to evaluate the efficacy and safety of genotype guided antiplatelet therapy in patients after percutaneous coronary intervention in East Asian"

Keywords

Access to Document

Other files and links

Cite this